New Key Statistics Module, Z-Score and F-Score
OTCPK:PHGUF Key Ratios
| Market Cap $ M | 540.40 |
| Enterprise Value $ M | 495.72 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 48.39 |
| Price/Book | 2.46 |
| Price/Sales | 2.01 |
| Price/Free Cash Flow | 246.00 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 285.00 |
| EPS (TTM) $ | -0.03 |
| Beneish M-Score | -2.66 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -19.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -53.08 |
| EV-to-EBITDA | 74.11 |
| PEG | -- |
| Shares Outstanding M | 678.35 |
| Net Margin (%) | -6.26 |
| Operating Margin % | -10.97 |
| Pre-tax Margin (%) | -6.05 |
| Quick Ratio | 2.76 |
| Current Ratio | 3.53 |
| ROA % (ttm) | -4.08 |
| ROE % (ttm) | -8.23 |
| ROIC % (ttm) | -16.11 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.93 |
PHGUF Number of Guru Trades
PHGUF Volume of Guru Trades
Gurus Latest Trades with OTCPK:PHGUF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:PHGUF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pharming Group Insider Transactions
No Available Data
News about OTCPK:PHGUF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers